Home NDC 33342-274 Febuxostat
Product NDC 33342-274
11-digit product format 333420274
Labeler code 33342
Product ID 33342-274_eb38172a-f884-4a94-be6d-73ad338fb29c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Febuxostat tablets 40 mg
Dosage form FILM
Route ORAL
Labeler Macleods Pharmaceuticals Limited
Application ANDA207293
Marketing category ANDA
Marketing start 2019-04-04
Substance FEBUXOSTAT
Active strength 40 mg/1
Pharmacologic classes Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207293-001 FEBUXOSTAT FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 A207293-002 FEBUXOSTAT FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A207293-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2023-09-28 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A207293-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2023-09-28 9b2671bbb829…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Febuxostat
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FEBUXOSTAT 40 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 101V0R1N2E Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 834235 Internal RxNorm lookup 834241 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 33342-274-07 Febuxostat 30 in 1 BOTTLE FILM 30 2 33342-274-10 Febuxostat 90 in 1 BOTTLE FILM 90 2 33342-274-15 Febuxostat 500 in 1 BOTTLE FILM 500 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 33342-274 FEBUXOSTAT (FEBUXOSTAT TABLETS 40 MG) FILM FEBUXOSTAT (FEBUXOSTAT TABLETS 80 MG) FILM [MACLEODS PHARMACEUTICALS LIMITED] 2 Current NDC, 3 package rows 20231012_77875ed1-049e-421b-a8d5-569b4af4a1b5.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Febuxostat FEBUXOSTAT TABLETS 40 MG Macleods Pharmaceuticals Limited 77875ed1-049e-421b-a8d5-569b4af4a1b5 2023-09-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 207293 application number: ANDA207293 ndc (product): 33342-274
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 33342-274-07 33342027407 30 FILM in 1 BOTTLE (33342-274-07) 30 film 2019-04-04 No No Current 33342-274-10 33342027410 90 FILM in 1 BOTTLE (33342-274-10) 90 film 2019-04-04 No No Current 33342-274-15 33342027415 500 FILM in 1 BOTTLE (33342-274-15) 500 film 2019-04-04 No No Current